Access the full text.
Sign up today, get DeepDyve free for 14 days.
Pleun Ketelaars, R. Bosgraaf, A. Siebers, Leon Massuger, J. Linden, C.A.P. Wauters, Janette Rahamat-Langendoen, A. Brule, Joanna IntHout, W. Melchers, R. Bekkers (2017)
High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.Preventive medicine, 101
C. Lenselink, R. Bie, D. Hamont, J. Bakkers, W. Quint, L. Massuger, R. Bekkers, W. Melchers (2009)
Detection and Genotyping of Human Papillomavirus in Self-Obtained Cervicovaginal Samples by Using the FTA Cartridge: New Possibilities for Cervical Cancer ScreeningJournal of Clinical Microbiology, 47
J. Cuzick, M. Arbyn, R. Sankaranarayanan, V. Tsu, G. Ronco, M. Mayrand, J. Dillner, C. Meijer (2008)
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine, 26 Suppl 10
M. Cremer, E. Conlisk, J. Felix (2009)
HPV screening for cervical cancer in rural India.The New England journal of medicine, 361 3
C. Wright (2008)
Cervical cancer screening- past present and futureSouthern African Journal of Infectious Diseases, 22
I. Gustavsson, K. Sanner, M. Lindell, A. Strand, M. Olovsson, I. Wikström, E. Wilander, U. Gyllensten (2011)
Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 51 4
J. Walboomers, M. Jacobs, M. Manos, F. Bosch, J. Kummer, K. Shah, P. Snijders, J. Peto, C. Meijer, N. Muñoz (1999)
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 189
Megan Smith, J. Lew, K. Simms, K. Canfell (2016)
Impact of HPV sample self‐collection for underscreened women in the renewed Cervical Screening ProgramMedical Journal of Australia, 204
Cobas ® 4800 HPV test
(2017)
Selfsampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial
(2011 Sep)
Whatman FTA technology
US Force, Susan Curry, A. Krist, Douglas Owens, Michael Barry, Aaron Caughey, Karina Davidson, Chyke Doubeni, J. Epling, Alex Kemper, Martha Kubik, C. Landefeld, Carol Mangione, Maureen Phipps, Michael Silverstein, Melissa Simon, Chien-Wen Tseng, John Wong (2018)
Screening for Cervical Cancer: US Preventive Services Task Force Recommendation StatementJAMA, 320
Hong Ying, Fang Jing, Fanghui Zhao, Youlin Qiao, Hu Yali (2014)
High-risk HPV nucleic acid detection kit–the careHPV test –a new detection method for screeningScientific Reports, 4
R. Bie, C. Schmeink, J. Bakkers, P. Snijders, W. Quint, L. Massuger, R. Bekkers, W. Melchers (2011)
The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions.The Journal of molecular diagnostics : JMD, 13 4
Y. Guan, P. Gravitt, Roslyn Howard, Y. Eby, Shaoming Wang, Belinda Li, Changyan Feng, Y. Qiao, P. Castle (2013)
Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens.Journal of virological methods, 189 1
Hongxue Luo, H. Du, K. Maurer, J. Belinson, Guixiang Wang, Zhihong Liu, Lijie Zhang, Yan-qiu Zhou, Chun Wang, Jinlong Tang, X. Qu, R. Wu (2016)
An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport MediaPLoS ONE, 11
Q. Feng, S. Cherne, R. Winer, V. Popov, Héctor Zambrano, Carlos Yerovi, S. Hawes, L. Koutsky, N. Kiviat (2010)
Evaluation of Transported Dry and Wet Cervical Exfoliated Samples for Detection of Human Papillomavirus InfectionJournal of Clinical Microbiology, 48
Li Dong, Chunqing Lin, Li Li, M. Wang, J. Cui, R. Feng, B. Liu, Zeni Wu, Jia Lian, G. Liao, Wen Chen, Y. Qiao (2017)
An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 94
M. Lindemann, Mario Dominguez, Jesús Antonio, M. Sandri, A. Tricca, M. Sideri, H. Khiri, Sophie Ravet, S. Boyle, Carrie Aldrich, P. Halfon (2012)
Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.The Journal of molecular diagnostics : JMD, 14 1
A. Goel, G. Gandhi, S. Batra, S. Bhambhani, V. Zutshi, P. Sachdeva (2005)
Visual inspection of the cervix with acetic acid for cervical intraepithelial lesionsInternational Journal of Gynecology & Obstetrics, 88
R Winer, JA Tiro, DL Miglioretti, C Thayer, T Beatty, J Lin (2019)
Corrigendum to “Rationale and design of the HOME trial: apragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system”, 84
T. Wright, M. Stoler, C. Behrens, Abha Sharma, Guili Zhang, T. Wright (2015)
Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.Gynecologic oncology, 136 2
I. Gustavsson, M. Lindell, E. Wilander, A. Strand, U. Gyllensten (2009)
Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 46 2
J. Ferlay, M. Colombet, I. Soerjomataram, C. Mathers, D. Parkin, M. Piñeros, A. Znaor, F. Bray (2018)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 144
Shaoming Wang, Shangying Hu, Wen Chen, Feng Chen, F. Zhao, Wei He, Xin-Ming Ma, Yu-Qing Zhang, Jian Wang, Priya Sivasubramaniam, Y. Qiao (2015)
Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screeningBMC Cancer, 15
F. Bray, J. Ferlay, I. Soerjomataram, R. Siegel, Lindsey Torre, A. Jemal (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 68
F. Sultana, D. Gertig, C. Wrede, D. English, J. Simpson, Kelly Drennan, J. Brotherton, G. Phillips, S. Heley, P. Castle, M. Saville (2015)
A pilot study to compare dry cervical sample collection with standard practice of wet cervical samples for human papillomavirus testing.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 69
D. Hegde, Harish Shetty, P. Shetty, Supriya Rai (2011)
Diagnostic value of acetic acid comparing with conventional Pap smear in the detection of colposcopic biopsy-proved CIN.Journal of cancer research and therapeutics, 7 4
G. Sawaya, M. Huchko (2017)
Cervical Cancer Screening.The Medical clinics of North America, 101 4
A. Virtanen, A. Anttila, T. Luostarinen, N. Malila, P. Nieminen (2015)
Improving cervical cancer screening attendance in FinlandInternational Journal of Cancer, 136
D. Geraets, R. Baars, Inmaculada Alonso, Jaume Ordi, Aureli Torné, Willem Melchers, Chris Meijer, W. Quint (2013)
Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 57 2
Introduction: Alternative methods of dry storage and transportation may be a viable alternative to the use of liquid storage medium for cervical samples, especially for screening programs in places with few resources. Objective: The objective of this study is to verify the viability and efficacy of human papillomavirus DNA (HPV-DNA) detection in cervical cell samples collected and stored on a Flinders Technology Associates (FTA) card (Whatman Indicating FTA<sup>®</sup> Elute Micro Card) and subsequently recovered in ethanol-based liquid medium and to compare the results to those obtained using samples stored directly in ethanol-based liquid medium. Study Design: Thirty-four women submitted to ETZ (excision of the transformation zone of the cervix) were included in this study. Before ETZ, 2 samples of exfoliated cervical cells were collected from each woman by a doctor and stored in ethanol-based liquid medium and on an FTA card. DNA recovery from FTA samples was performed using ethanol-based liquid medium. Detection of HPV-DNA in the samples was performed using the Cobas® 4800 HPV Test Platform. Results and Conclusions: The HPV-DNA detection positivity rates were 70.6% for the samples collected directly in liquid medium and 64.7% for the samples stored on the FTA card, with high detection accuracy in the DNA samples recovered from the FTA card (area under the curve = 0.958; 95% confidence interval = 0.890–1.000). The concordance between the results obtained using the 2 storage media was 94.1% (Kappa = 0.866). These preliminary results suggest that collection of cervical material on an FTA card may be an alternative to storage in liquid medium since the liquid medium has some limitations. In addition, DNA recovery from the card using ethanol-based liquid medium streamlines the workflow in the laboratory and reduces the cost associated with reagents, thereby facilitating access to the HPV test in places with few resources and potentially improving cervical cancer screening.
Acta Cytologica – Karger
Published: Jun 1, 2021
Keywords: Human papillomavirus; Human papillomavirus test; Filter paper
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.